Charcot Foot: Recognizing and Treating Diabetic Neuropathic Arthropathy

▶ Watch

Charcot neuropathic osteoarthropathy — commonly called Charcot foot — is one of the most devastating and poorly understood complications of diabetic peripheral neuropathy. It is also one of the most commonly misdiagnosed, with initial presentation frequently confused with acute cellulitis or gout. The difference in outcome between prompt correct diagnosis and delayed or incorrect management can mean the difference between a foot that remains functional and one that requires amputation.

What Is Charcot Foot?

Charcot foot is a progressive bone and joint destruction process that occurs in patients with peripheral neuropathy — most commonly diabetic neuropathy, but also HIV neuropathy, alcohol-related neuropathy, and other causes of profound sensory loss. The underlying mechanism involves a combination of repetitive unrecognized microtrauma (the patient cannot feel the injury) and an exaggerated neurogenic inflammatory response that triggers osteoclastic bone resorption, fracture, and progressive joint dislocation.

The result, if untreated, is progressive collapse of the midfoot into a “rocker-bottom” deformity with severe bony prominences that create high-risk ulceration sites — the final pathway to limb-threatening infection and amputation.

The Classic Presentation — And Why It’s Missed

The acute Charcot foot presents as a warm, swollen, erythematous (red) foot in a diabetic patient with peripheral neuropathy. Temperature differential between the affected foot and the contralateral foot is typically 3–7°C, measurable with an infrared thermometer. Critically, pain is minimal or absent despite dramatic swelling and warmth — because neuropathy prevents normal pain perception.

This presentation is routinely misdiagnosed as:

• Cellulitis — the most common misdiagnosis; treated with antibiotics while the Charcot destruction progresses
• Gout — particularly when the ankle or midfoot are involved
• DVT — when calf swelling accompanies the foot edema
• Ankle sprain — when there is a history of minor preceding trauma

The key distinguishing feature: a diabetic patient with neuropathy who has a warm swollen foot but relatively minimal pain should be presumed to have Charcot foot until proven otherwise.

Staging: Eichenholtz Classification

The Eichenholtz staging system describes Charcot progression:

• Stage 0 (Pre-radiographic): Warm swollen foot, X-rays appear normal; MRI shows bone marrow edema. This is the critical stage for intervention.
• Stage 1 (Development/Fragmentation): X-rays show fracture, fragmentation, and joint dislocation. Dramatic bone destruction occurs over weeks to months if not immobilized.
• Stage 2 (Coalescence): Acute inflammation subsides; fractured bone begins to consolidate. Foot temperature normalizes.
• Stage 3 (Reconstruction/Consolidation): Bone consolidates in whatever deformed position it has assumed. Chronic stage — surgical reconstruction considered if deformity creates ulceration risk.

Treatment

Acute Charcot (Stages 0–1): Total contact casting (TCC) and strict non-weight bearing is the cornerstone of acute Charcot management. Immobilization prevents further bony destruction and deformity progression. Treatment continues for months — until the foot temperature normalizes and X-rays confirm consolidation. Bisphosphonate therapy (zoledronate or pamidronate) may be used adjunctively to reduce osteoclastic activity during the acute phase.

Chronic Charcot with deformity (Stage 3): Patients with rocker-bottom deformity and bony prominences that cannot be accommodated with custom Charcot restraint orthotic walker (CROW) shoes require surgical reconstruction — Charcot reconstruction with osteotomy and internal fixation to correct deformity and eliminate the high-risk prominences. This is complex reconstructive surgery requiring careful preoperative planning and prolonged postoperative management.

Prevention Through Surveillance

Diabetic patients with peripheral neuropathy should perform daily bilateral foot temperature monitoring with an infrared thermometer — a sustained asymmetric temperature increase of ≥4°F between feet warrants same-day podiatric evaluation. Early detection at Stage 0 prevents the catastrophic deformity of untreated progression.

Your Board-Certified Podiatrists

Dr. Tom Biernacki, DPM

Board-Certified · FACFAS

Dr. Carl Jay, DPM

Board-Certified Podiatrist

Dr. Daria Gutkin, DPM

Podiatrist

Dr. Tom Biernacki, DPM

Affiliate Disclosure: This page contains affiliate links to products we recommend. If you purchase through these links, Balance Foot & Ankle may earn a small commission at no additional cost to you. We only recommend products we use with our patients.

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.